Future Diagnostic Strategies-Pediatric

H. C. DeSena, Benjamin Landis, R. A. Moore, D. S. Spar, W. Whiteside, Burns C. Blaxall

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The physicians and patients involved in the early advancement of treatments for pediatric cardioskeletal myopathies have long been regarded as "passionate risk-takers." With each new procedure creating room for innovation and the robust incorporation of science related to clinical and surgical outcomes, the morbidity and mortality of pediatric heart disease has continued to decline; it is now often regarded as a chronic medical condition instead of a terminal diagnosis. However, as with any disease process, appropriate and innovative treatments rely entirely on accurate diagnoses. In this chapter, we will discuss current and emerging diagnostic strategies for pediatric heart disease that promise to further advance the field. Although there are myriad innovative advances being made to refine and enhance diagnostic accuracy in pediatric heart disease, we will focus on five main areas: noninvasive imaging, electrophysiology, invasive procedures, monitoring in the cardiac intensive care unit, and genetics.

Original languageEnglish (US)
Title of host publicationCardioskeletal Myopathies in Children and Young Adults
PublisherElsevier Inc.
Pages361-379
Number of pages19
ISBN (Print)9780128000403
DOIs
StatePublished - Nov 15 2016

Fingerprint

Pediatrics
Heart Diseases
Electrophysiology
Muscular Diseases
Intensive Care Units
Morbidity
Physicians
Mortality
Therapeutics

Keywords

  • Diagnostic
  • Future
  • Pediatric
  • Strategies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

DeSena, H. C., Landis, B., Moore, R. A., Spar, D. S., Whiteside, W., & Blaxall, B. C. (2016). Future Diagnostic Strategies-Pediatric. In Cardioskeletal Myopathies in Children and Young Adults (pp. 361-379). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800040-3.00018-2

Future Diagnostic Strategies-Pediatric. / DeSena, H. C.; Landis, Benjamin; Moore, R. A.; Spar, D. S.; Whiteside, W.; Blaxall, Burns C.

Cardioskeletal Myopathies in Children and Young Adults. Elsevier Inc., 2016. p. 361-379.

Research output: Chapter in Book/Report/Conference proceedingChapter

DeSena, HC, Landis, B, Moore, RA, Spar, DS, Whiteside, W & Blaxall, BC 2016, Future Diagnostic Strategies-Pediatric. in Cardioskeletal Myopathies in Children and Young Adults. Elsevier Inc., pp. 361-379. https://doi.org/10.1016/B978-0-12-800040-3.00018-2
DeSena HC, Landis B, Moore RA, Spar DS, Whiteside W, Blaxall BC. Future Diagnostic Strategies-Pediatric. In Cardioskeletal Myopathies in Children and Young Adults. Elsevier Inc. 2016. p. 361-379 https://doi.org/10.1016/B978-0-12-800040-3.00018-2
DeSena, H. C. ; Landis, Benjamin ; Moore, R. A. ; Spar, D. S. ; Whiteside, W. ; Blaxall, Burns C. / Future Diagnostic Strategies-Pediatric. Cardioskeletal Myopathies in Children and Young Adults. Elsevier Inc., 2016. pp. 361-379
@inbook{b0f6e416eb4049f5af9a1867b25adcf0,
title = "Future Diagnostic Strategies-Pediatric",
abstract = "The physicians and patients involved in the early advancement of treatments for pediatric cardioskeletal myopathies have long been regarded as {"}passionate risk-takers.{"} With each new procedure creating room for innovation and the robust incorporation of science related to clinical and surgical outcomes, the morbidity and mortality of pediatric heart disease has continued to decline; it is now often regarded as a chronic medical condition instead of a terminal diagnosis. However, as with any disease process, appropriate and innovative treatments rely entirely on accurate diagnoses. In this chapter, we will discuss current and emerging diagnostic strategies for pediatric heart disease that promise to further advance the field. Although there are myriad innovative advances being made to refine and enhance diagnostic accuracy in pediatric heart disease, we will focus on five main areas: noninvasive imaging, electrophysiology, invasive procedures, monitoring in the cardiac intensive care unit, and genetics.",
keywords = "Diagnostic, Future, Pediatric, Strategies",
author = "DeSena, {H. C.} and Benjamin Landis and Moore, {R. A.} and Spar, {D. S.} and W. Whiteside and Blaxall, {Burns C.}",
year = "2016",
month = "11",
day = "15",
doi = "10.1016/B978-0-12-800040-3.00018-2",
language = "English (US)",
isbn = "9780128000403",
pages = "361--379",
booktitle = "Cardioskeletal Myopathies in Children and Young Adults",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Future Diagnostic Strategies-Pediatric

AU - DeSena, H. C.

AU - Landis, Benjamin

AU - Moore, R. A.

AU - Spar, D. S.

AU - Whiteside, W.

AU - Blaxall, Burns C.

PY - 2016/11/15

Y1 - 2016/11/15

N2 - The physicians and patients involved in the early advancement of treatments for pediatric cardioskeletal myopathies have long been regarded as "passionate risk-takers." With each new procedure creating room for innovation and the robust incorporation of science related to clinical and surgical outcomes, the morbidity and mortality of pediatric heart disease has continued to decline; it is now often regarded as a chronic medical condition instead of a terminal diagnosis. However, as with any disease process, appropriate and innovative treatments rely entirely on accurate diagnoses. In this chapter, we will discuss current and emerging diagnostic strategies for pediatric heart disease that promise to further advance the field. Although there are myriad innovative advances being made to refine and enhance diagnostic accuracy in pediatric heart disease, we will focus on five main areas: noninvasive imaging, electrophysiology, invasive procedures, monitoring in the cardiac intensive care unit, and genetics.

AB - The physicians and patients involved in the early advancement of treatments for pediatric cardioskeletal myopathies have long been regarded as "passionate risk-takers." With each new procedure creating room for innovation and the robust incorporation of science related to clinical and surgical outcomes, the morbidity and mortality of pediatric heart disease has continued to decline; it is now often regarded as a chronic medical condition instead of a terminal diagnosis. However, as with any disease process, appropriate and innovative treatments rely entirely on accurate diagnoses. In this chapter, we will discuss current and emerging diagnostic strategies for pediatric heart disease that promise to further advance the field. Although there are myriad innovative advances being made to refine and enhance diagnostic accuracy in pediatric heart disease, we will focus on five main areas: noninvasive imaging, electrophysiology, invasive procedures, monitoring in the cardiac intensive care unit, and genetics.

KW - Diagnostic

KW - Future

KW - Pediatric

KW - Strategies

UR - http://www.scopus.com/inward/record.url?scp=85009833766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009833766&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800040-3.00018-2

DO - 10.1016/B978-0-12-800040-3.00018-2

M3 - Chapter

AN - SCOPUS:85009833766

SN - 9780128000403

SP - 361

EP - 379

BT - Cardioskeletal Myopathies in Children and Young Adults

PB - Elsevier Inc.

ER -